Quick Takeaways
- Deep Track Capital, LP filed SCHEDULE 13G for Ikena Oncology, Inc. Common Stock, $0.001 par value (IKNA).
- Disclosed ownership: 5.2%.
- Date of event: 07 Feb 2025.
Deep Track Capital, LP - 07 Feb 2025 SCHEDULE 13G Report for Ikena Oncology, Inc. Common Stock, $0.001 par value (IKNA)
- Filing Manager
- Deep Track Capital, LP
- Reporting Manager
- Deep Track Capital, LP
- Symbol
- IKNA
- Shares outstanding
- 48,282,399 shares
- Disclosed Ownership
- 2,515,513 shares
- Ownership
- 5.2%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Feb 2025, 16:32:11 UTC
- Date of event
- 07 Feb 2025
- Next filing
- 04 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Deep Track Capital, LP disclosed 5.2% ownership in Ikena Oncology, Inc. Common Stock, $0.001 par value (IKNA) on 07 Feb 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 16:32.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Deep Track Capital, LP | 5.2% | 2,515,513 | 0 | 2,515,513 | /s/ David Kroin | David Kroin, Managing Member of the General Partner of the Investment Adviser | |
| Deep Track Biotechnology Master Fund, Ltd. | 5.2% | 2,515,513 | 0 | 2,515,513 | /s/ David Kroin | David Kroin, Director | |
| David Kroin | 5.2% | 2,515,513 | 0 | 2,515,513 | /s/ David Kroin | David Kroin |